Advertisement

AAPS PharmSciTech

, Volume 19, Issue 5, pp 2023–2040 | Cite as

Characterization of Lipid-Based Lyotropic Liquid Crystal and Effects of Guest Molecules on Its Microstructure: a Systematic Review

  • Xingqi Wang
  • Yong Zhang
  • Shuangying Gui
  • Jie Huang
  • Jiaojiao Cao
  • Zhengguang Li
  • Qian Li
  • Xiaoqin Chu
Review Article

Abstract

Liquid crystals (LCs) are conventionally divided into thermotropic or lyotropic, based on the organization and sequence of the controlled molecular system. Lipid-based lyotropic liquid crystal (LLC), such as lamellar (Lα), bicontinuous cubic (QII), or hexagonal (HII) phases, have attracted wide interest in the last few decades due to their practical potential in diverse applications and notable structural complexity. Various guest molecules, such as biopharmaceuticals, chemicals, and additives, can be solubilized in either aqueous or oily phase. And the LLC microstructure can be altered to affect the rate of drug release eventually. To utilize these microstructural variations to adjust the drug release in drug delivery system (DDS), it is crucial to understand the structure variations of the LLC caused by different types of guest molecules. Therefore, in this article, we review the effect of guest molecules on lipid-based LLC microstructures. In particular, we focus on the different characterization methods to evaluate this change caused by guest substances, such as polarized light microscopy (PLM), small-angle X-ray scattering (SAXS), Fourier-transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), self-diffusion nuclear magnetic resonance (SD-NMR), and so on.

KEY WORDS

lyotropic liquid crystal glyceryl monooleate phytantriol guest molecules characterization methods 

Notes

Acknowledgments

Many thanks are also expressed to Xiaoqin Chu for useful discussions.

Funding Information

We are grateful for the financial supports from National Natural Science Foundation of China (No. 81274099), Anhui Provincial Talents Project for youth in Universities (No. gxyq2018025), Anhui Provincial Natural Science Foundation (No. 1408085QH183), and Exploratory Research Projects of Anhui University of Chinese Medicine (No. 2016ts066).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that there is no conflict of interest.

References

  1. 1.
    Mulet X, Boyd BJ, Drummond CJ. Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions. J Colloid Interface Sci. 2013;393:1–20.  https://doi.org/10.1016/j.jcis.2012.10.014.CrossRefGoogle Scholar
  2. 2.
    Liron BC, Libster D, Aserin A, et al. Complex dendrimer lyotropic liquid crystalline systems: structural behavior and interactions. J Phys Chem. 2011;115:11984–92.  https://doi.org/10.1021/jp2030939.CrossRefGoogle Scholar
  3. 3.
    Guo CY, Wang J, Cao FL, Lee RJ, Zhai G. Lyotropic liquid crystal systems in drug delivery. Drug Discov Today. 2010;15:1032–40.  https://doi.org/10.1016/j.drudis.2010.09.006.CrossRefGoogle Scholar
  4. 4.
    Rajabalaya R, Musa MN, Kifli N, David SR. Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Des Devel Ther. 2017;11:393–406.  https://doi.org/10.2147/DDDT.S103505.eCollection2017.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wang D, Cao YY, Cao MW, Sun Y, Wang J, Hao J. Dual-responsive viscoelastic lyotropic liquid crystal fluids to control the diffusion of hydrophilic and hydrophobic molecules. ChemPhysChem. 2016;17:1–10.  https://doi.org/10.1002/cphc.201600066.CrossRefGoogle Scholar
  6. 6.
    Souza JF, Pontes KS, Alves TFR, et al. Spotlight on biomimetic systems based on lyotropic liquid crystal. Molecules. 2017;22:419.  https://doi.org/10.3390/molecules22030419.CrossRefGoogle Scholar
  7. 7.
    Akbar S, Anwar A, Ayish A, Elliott JM, Squires AM. Phytantriol based smart nano-carriers for drug delivery applications. Eur J Pharm Sci. 2017;101:31–42.  https://doi.org/10.1016/j.ejps.2017.01.035.CrossRefGoogle Scholar
  8. 8.
    Tangso KJ, Fong WK, Darwish T, Kirby N, Boyd BJ, Hanley TL. Novel spiropyran amphiphiles and their application as light-responsive liquid crystalline components. J Phys Chem. 2013;117:10203–10.  https://doi.org/10.1021/jp403840m.CrossRefGoogle Scholar
  9. 9.
    Poletto FS, Lima FS, Lundberg D, Nylander T, Loh W. Tailoring the internal structure of liquid crystalline nanoparticles responsive to fungal lipases: a potential platform for sustained drug release. Colloids Surf B: Biointerfaces. 2016;147:210–6.  https://doi.org/10.1016/j.colsurfb.2016.08.003.CrossRefGoogle Scholar
  10. 10.
    Liu QT, Wang JF, Dong YD, Boyd BJ. Using a selective cadmium-binding peplipid to create responsive liquid crystalline nanomaterials. J Colloid Interface Sci. 2015;449:122–9.  https://doi.org/10.1016/j.jcis.2014.11.063.CrossRefGoogle Scholar
  11. 11.
    Adwan S, Rana AD, Al-Bakri AG, et al. Glyceryl monooleate-based otic delivery system of ofloxacin: release profile and bactericidal activity. Pharm Dev Technol. 2015;20:361–6.  https://doi.org/10.3109/10837450.2013.871030.CrossRefGoogle Scholar
  12. 12.
    Lee KWY, guyen THN, Hanley T, et al. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. Int J Pharm. 2009;365:190–9.  https://doi.org/10.1016/j.ijpharm.2008.08.022.CrossRefGoogle Scholar
  13. 13.
    Milak S, Zimmer A. Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm. 2015;478:569–87.  https://doi.org/10.1016/j.ijpharm.2014.11.072.CrossRefGoogle Scholar
  14. 14.
    Boyd BJ, Khoo SM, Whittaker DV, et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int J Pharm. 2007;340:52–60.  https://doi.org/10.1016/j.ijpharm.2007.03.020.CrossRefGoogle Scholar
  15. 15.
    Tran N, Mulet X, Hawley AM, Conn CE, Zhai J, Waddington LJ, et al. First direct observation of stable internally ordered janus nanoparticles created by lipid self-assembly. Nano Lett. 2015;15:4229–33.  https://doi.org/10.1021/acs.nanolett.5b01751.CrossRefGoogle Scholar
  16. 16.
    Klaus A, Tiddy GJT, Touraud D, Schramm A, Stühler G, Kunz W. Phase behavior of an extended surfactant in water and a detailed characterization of the concentrated phases. Langmuir. 2010;26:16871–83.  https://doi.org/10.1021/la103037q.CrossRefGoogle Scholar
  17. 17.
    Quinn MDJ, Wang T, Du JD, et al. Graphene as a photothermal actuator for control of lipid mesophase structure. Nano. 2017;9:341–8.  https://doi.org/10.1039/c6nr08185a.CrossRefGoogle Scholar
  18. 18.
    Idit AY, Garti N. Transitions induced by solubilized fat into reverse hexagonal mesophases. Colloids Surf B: Biointerfaces. 2005;43:72–82.  https://doi.org/10.1016/j.colsurfb.2005.03.011.CrossRefGoogle Scholar
  19. 19.
    Pan X, Han K, Peng XS, Yang Z, Qin L, Zhu C, et al. Nanostructured cubic as advanced drug delivery system. Curr Pharm Des. 2013;19:6290–7.CrossRefGoogle Scholar
  20. 20.
    Hag LV, Gras SL, Conn CE, et al. Lyotropic liquid crystal engineering moving beyond binary compositional space-ordered nanostructured amphiphile self-assembly materials by design. Chem Soc Rev. 2017;46:2705–31.  https://doi.org/10.1039/c6cs00663a.CrossRefGoogle Scholar
  21. 21.
    Shrestha LK, Shrestha RG, Aramaki K, et al. Structure and rheology of charge-free reverse micelles in aromatic liquid phenyloctane. J Nanosci Nanotechnol. 2012;12:3701–15.  https://doi.org/10.1166/jnn.2012.6170.CrossRefGoogle Scholar
  22. 22.
    Phan S, Fong WK, Kirby N, Hanley T, Boyd BJ. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm. 2011;421:176–82.  https://doi.org/10.1016/j.ijpharm.2011.09.022.CrossRefGoogle Scholar
  23. 23.
    Zabara A, Mezzenga R. Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases. J Control Release. 2014;188:31–43.  https://doi.org/10.1016/j.jconrel.2014.05.052.CrossRefGoogle Scholar
  24. 24.
    Li QT, Wang XD, Yue X, Chen X. Unique phase behaviors in the gemini surfactant/EAN binary system: the role of the hydroxyl group. Langmuir. 2015;31:13511–8.  https://doi.org/10.1021/acs.langmuir.5b03809.CrossRefGoogle Scholar
  25. 25.
    Marganit CA, Aserin A, Garti N. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf B: Biointerfaces. 2010;77:131–8.  https://doi.org/10.1016/j.colsurfb.2010.01.013.CrossRefGoogle Scholar
  26. 26.
    Borgheti-Cardoso LN, Depieri LV, Kooijmans SAA, Diniz H, Calzzani RAJ, Vicentini FTMC, et al. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. Eur J Pharm Sci. 2015;74:103–17.  https://doi.org/10.1016/j.ejps.2015.04.017.CrossRefGoogle Scholar
  27. 27.
    Sugosh R, Prabhu, Dutt GB. Can critical packing parameter depict probe rotation in block-copolymer reverse micelles? J Phys Chem. 2013;117:5868–74.  https://doi.org/10.1021/jp4022807.CrossRefGoogle Scholar
  28. 28.
    Zhai JL, Tran N, Sarkar S, Fong C, Mulet X, Drummond CJ. Self-assembled lyotropic liquid crystalline phase behavior of monoolein-capric acid-phospholipid nanoparticulate systems. Langmuir. 2017;33:2571–80.  https://doi.org/10.1021/acs.langmuir.6b04045.CrossRefGoogle Scholar
  29. 29.
    Azhari H, Strauss M, Hook S. Stabilising cubic with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier. Eur J Pharm Biopharm. 2016;104:148–55.  https://doi.org/10.1016/j.ejpb.2016.05.001.CrossRefGoogle Scholar
  30. 30.
    Fong C, Le T, Calum JD, et al. Lyotropic liquid crystal engineering-ordered nanostructured small molecule amphiphile self-assembly materials by design. Chem Soc Rev. 2012;41:1297–322.  https://doi.org/10.1039/c1cs15148g.CrossRefGoogle Scholar
  31. 31.
    Rizwan SB, Boyd BJ, Rades T. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opin Drug Deliv. 2010;7:1133–44.  https://doi.org/10.1517/17425247.2010.515584.CrossRefGoogle Scholar
  32. 32.
    Chen YL, Ma P, Gui SY. Cubic and hexagonal liquid crystals as drug delivery systems. Biomed Res Int. 2014;2014:815981.  https://doi.org/10.1155/2014/815981.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Nelli RK, Aleandri S, Speziale C, et al. Stimuli-responsive lipidic cubic phase: triggered release and sequestration of guest molecules. Chem Eur J. 2015;21:1873–7.  https://doi.org/10.1002/chem.201405580.CrossRefGoogle Scholar
  34. 34.
    Fong WK, Hanley T, Boyd BJ. Stimuli responsive liquid crystals provide ‘on-demand’ drug delivery in vitro and in vivo. J Control Release. 2009;135:218–26.  https://doi.org/10.1016/j.jconrel.2009.01.009.CrossRefGoogle Scholar
  35. 35.
    Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling and release kinetics. J Pharm Sci. 2009;98:4191–204.  https://doi.org/10.1002/jps.21724.CrossRefGoogle Scholar
  36. 36.
    Achrai B, Libster D, Aserin A, Garti N. Solubilization of gabapentin into HII mesophases. J Phys Chem. 2011;115:825–35.  https://doi.org/10.1021/jp108801d.CrossRefGoogle Scholar
  37. 37.
    Mei LL, Xie YC, Huang XT, et al. An injectable in situ gel with cubic and hexagonal nanostructures for local treatment of chronic periodontitis. Drug Deliv. 2017;24:1148–58.  https://doi.org/10.1080/10717544.2017.1359703.CrossRefGoogle Scholar
  38. 38.
    Qin LZ, Mei LL, Shan ZY, Huang Y, Pan X, Li G, et al. Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent. Drug Dev Ind Pharm. 2016;42:307–16.  https://doi.org/10.3109/03639045.2015.1052079.CrossRefGoogle Scholar
  39. 39.
    Garti N, Hoshen G, Aserin A. Lipolysis and structure controlled drug release from reversed hexagonal mesophase. Colloids Surf B: Biointerfaces. 2012;94:36–43.  https://doi.org/10.1016/j.colsurfb.2012.01.013.CrossRefGoogle Scholar
  40. 40.
    Marganit CA, Aserin A, Garti N. HII mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf B: Biointerfaces. 2010;77:131–8.  https://doi.org/10.1016/j.colsurfb.2010.01.013.CrossRefGoogle Scholar
  41. 41.
    Liron BC, Idit YA, Abraham A, et al. Solubilization of vitamin E into HIILLC mesophase in the presence and in the absence of vitamin C. Langmuir. 2010;26:3648–53.  https://doi.org/10.1021/la903100m.CrossRefGoogle Scholar
  42. 42.
    Liang X, Chen YL, Jiang XJ, Wang SM, Zhang JW, Gui SY. HII mesophase as a drug delivery system for topical application of methyl salicylate. Eur J Pharm Sci. 2017;100:155–62.  https://doi.org/10.1016/j.ejps.2016.12.033.CrossRefGoogle Scholar
  43. 43.
    Chen YL, Liang X, Ma P, Tao Y, Wu X, Wu X, et al. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration. AAPS PharmSciTech. 2015;16:846–54.  https://doi.org/10.1208/s12249-014-0277-6.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Manish HS, Anant PK. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. Int J Pharm. 2005;294:161–71.  https://doi.org/10.1016/j.ijpharm.2005.01.019.CrossRefGoogle Scholar
  45. 45.
    Meike H, Stefan M, Christel C, et al. Thermotropic transition structures in the ternary system lecithin/isopropyl myristate/water. Colloids Surf A Physicochem Eng Asp. 2005;259:81–7.  https://doi.org/10.1016/j.colsurfa.2005.02.013.CrossRefGoogle Scholar
  46. 46.
    Patil SS, Venugopal E, Bhat S, Mahadik KR, Paradkar AR. Mapping ion-induced mesophasic transformation in lyotropic in situ gelling system and its correlation with pharmaceutical performance. Pharm Res. 2013;30:1906–14.  https://doi.org/10.1007/s11095-013-1033-4.CrossRefGoogle Scholar
  47. 47.
    Scott JF, Xavier M, Adrian H, et al. Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions. J Colloid Interface Sci. 2013;408:117–24.  https://doi.org/10.1016/j.jcis.2013.07.002.CrossRefGoogle Scholar
  48. 48.
    Franc M, Anniina S, Otto G, et al. Monoglyceride-based cubic stabilized by laponite: separating the effects of stabilizer, pH and temperature. Colloids Surf A Physicochem Eng Asp. 2010;358:50–6.  https://doi.org/10.1016/j.colsurfa.2010.01.021.CrossRefGoogle Scholar
  49. 49.
    Kim DH, Lim S, Shim JW, Song JE, Chang JS, Jin KS, et al. A simple evaporation method for large-scale production of liquid crystalline lipid nanoparticles with various internal structures. ACS Appl Mater Interfaces. 2015;7:20438–46.  https://doi.org/10.1021/acsami.5b06413.CrossRefGoogle Scholar
  50. 50.
    Matthew JD, Oleksandr OM, Steven PA. A vesicle-to-worm transition provides a new high-temperature oil thickening mechanism. Angew Chem Int Ed. 2017;56:1–6.  https://doi.org/10.1002/anie.201609365.CrossRefGoogle Scholar
  51. 51.
    Kristian JT, Paulo HC, Patrick S, et al. Antimicrobial activity from colistin-heparin lamellar-phase complexes for the coating of biomedical devices. ACS Appl Mater Interfaces. 2016;8:31321–9.  https://doi.org/10.1021/acsami.6b10027.CrossRefGoogle Scholar
  52. 52.
    Serena M, Leandro RS, Sergio SF, et al. Cytochrome-c affects the monoolein polymorphism: consequences for stability and loading efficiency of drug delivery systems. Langmuir. 2016;32:873–81.  https://doi.org/10.1021/acs.langmuir.5b03507.CrossRefGoogle Scholar
  53. 53.
    Alexey K, Azat B, Olsson U, et al. DNA with double-chained amphiphilic counterions and its interaction with lecithin. Langmuir. 2012;28:13698–704.  https://doi.org/10.1021/la302720d.CrossRefGoogle Scholar
  54. 54.
    Seyedeh PA, Ribeiro IR, Ben JB, et al. Impact of preparation method and variables on the internal structure, morphology, and presence of liposomes in phytantriol-Pluronic® F127 cubic. Colloids Surf B: Biointerfaces. 2016;145:845–53.  https://doi.org/10.1016/j.colsurfb.2016.05.091.CrossRefGoogle Scholar
  55. 55.
    Idit AY, Doron A, Tehila M, et al. The role of glycerol and phosphatidylcholine in solubilizing and enhancing insulin stability in reverse hexagonal mesophases. J Colloid Interface Sci. 2011;364:379–87.  https://doi.org/10.1016/j.jcis.2011.05.047.CrossRefGoogle Scholar
  56. 56.
    Mei LL, Xie YC, Huang Y, Wang B, Chen J, Quan G, et al. Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia. Acta Biomater. 2017;17:30754–67.  https://doi.org/10.1016/j.actbio.2017.11.057.CrossRefGoogle Scholar
  57. 57.
    Anan Y, Barbara S, Michael R. Self-assembled nanostructures of fully hydrated monoelaidin-elaidic acid and monoelaidin-oleic acid systems. Langmuir. 2012;28:10105–19.  https://doi.org/10.1021/la3019716.CrossRefGoogle Scholar
  58. 58.
    Dima L, Abraham A, Doron Y, et al. Soft matter dispersions with ordered inner structures, stabilized by ethoxylated phytosterols. Colloids Surf B: Biointerfaces. 2009;74:202–15.  https://doi.org/10.1016/j.colsurfb.2009.07.020.CrossRefGoogle Scholar
  59. 59.
    Shen HH, Jonathan GC, Florian H, et al. The influence of dipalmitoyl phosphatidylserine on phase behaviour of and cellular response to lyotropic liquid crystalline dispersions. Biomaterials. 2010;31:9473–81.  https://doi.org/10.1016/j.biomaterials.2010.08.030.CrossRefGoogle Scholar
  60. 60.
    Tran N, Hawley A, Zhai JL, et al. High-throughput screening of saturated fatty acid influence on nanostructure of lyotropic liquid crystalline lipid nanoparticles. Langmuir. 2016;32:4509–20.  https://doi.org/10.1021/acs.langmuir.5b03769.CrossRefGoogle Scholar
  61. 61.
    Adam JT, Calum JD, Ben JB, et al. Disposition and association of the steric stabilizer Pluronic® F127 in lyotropic liquid crystalline nanostructured particle dispersions. J Colloid Interface Sci. 2013;392:288–96.  https://doi.org/10.1016/j.jcis.2012.09.051.CrossRefGoogle Scholar
  62. 62.
    Wibroe PP, Mat Azmi ID, Nilsson C, et al. Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: towards development of safe tunable intravenous lipid nanocarriers. Nanomedicine. 2015;11:1909–14.  https://doi.org/10.1016/j.nano.2015.08.003.CrossRefGoogle Scholar
  63. 63.
    Georgeta P, Justas B, Tommy N, et al. Liquid crystalline phases and their dispersions in aqueous mixtures of glycerol monooleate and glyceryl monooleyl ether. Langmuir. 2007;23:496–503.  https://doi.org/10.1021/la062344u.CrossRefGoogle Scholar
  64. 64.
    Christa N, Brianda BL, Annukka K, et al. SPECT/CT imaging of radiolabeled cubic and hexagonal for potential theranostic applications. Biomaterials. 2013;34:8491–503.  https://doi.org/10.1016/j.biomaterials.2013.07.055.CrossRefGoogle Scholar
  65. 65.
    Tehila MB, Abraham A, Nissim G. Structural properties and release of insulin-loaded reverse hexagonal (HII) liquid crystalline mesophase. J Colloid Interface Sci. 2017;486:184–93.  https://doi.org/10.1016/j.jcis.2016.09.074.CrossRefGoogle Scholar
  66. 66.
    Marganit CA, Dima L, Abraham A, et al. Penetratin-induced transdermal delivery from HII mesophases of sodium diclofenac. J Control Release. 2012;159:419–28.  https://doi.org/10.1016/j.jconrel.2012.01.025.CrossRefGoogle Scholar
  67. 67.
    Nicole BB, Ben JB, Dong YD, et al. Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules. Int J Pharm. 2015;495:241–8.  https://doi.org/10.1016/j.ijpharm.2015.08.072.CrossRefGoogle Scholar
  68. 68.
    Ashraf MD, Noguchi SJ, Iwao Y, et al. Preparation and characterization of SN-38-encapsulated phytantriol cubic containing α-monoglyceride additives. Chem Pharm Bull. 2016;64:577–84.  https://doi.org/10.1248/cpb.c15-00984.CrossRefGoogle Scholar
  69. 69.
    Anan Y, Liliana DC, Laurent S, et al. Control of the internal structure of MLO-based isasomes by the addition of diglycerol monooleate and soybean phosphatidylcholine. Langmuir. 2006;22:9919–27.  https://doi.org/10.1021/la061303v.CrossRefGoogle Scholar
  70. 70.
    Sagalowicz L, Guillot S, Acquistapace S, Schmitt B, Maurer M, Yaghmur A, et al. Influence of vitamin E acetate and other lipids on the phase behavior of mesophases based on unsaturated monoglycerides. Langmuir. 2013;29:8222–32.  https://doi.org/10.1021/la305052q.CrossRefGoogle Scholar
  71. 71.
    Tehila M, Paul BI, Dmitry B, et al. Modulation of physical properties of reverse hexagonal mesophases: a dielectric spectroscopy study. J Colloid Interface Sci. 2013;396:178–86.  https://doi.org/10.1016/j.jcis.2012.12.067.CrossRefGoogle Scholar
  72. 72.
    Renata N, Raffaele M. Diffusion, molecular separation, and drug delivery from lipid mesophases with tunable water channels. Langmuir. 2012;28:16455–62.  https://doi.org/10.1021/la303833s.CrossRefGoogle Scholar
  73. 73.
    Marganit CA, Alexander IS, Francesca MO, et al. On the correlation between the structure of lyotropic carriers and the delivery profiles of two common NSAIDs. Colloids Surf B: Biointerfaces. 2014;122:231–40.  https://doi.org/10.1016/j.colsurfb.2014.04.026.CrossRefGoogle Scholar
  74. 74.
    Liron BC, Abraham A, Garti N. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid. Colloids Surf B: Biointerfaces. 2013;112:87–95.  https://doi.org/10.1016/j.colsurfb.2013.06.051.CrossRefGoogle Scholar
  75. 75.
    Dima L, Abraham A, Ellen W, et al. An HII liquid crystal-based delivery system for cyclosporin A: physical characterization. J Colloid Interface Sci. 2007;308:514–24.  https://doi.org/10.1016/j.jcis.2006.12.084.CrossRefGoogle Scholar
  76. 76.
    Jonas GF, Helena LW, Mats A, et al. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir. 1997;13:6964–71.CrossRefGoogle Scholar
  77. 77.
    Idit AY, Ellen W, Einav BS, et al. Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir. 2007;23:637–3645.  https://doi.org/10.1021/la062851b.CrossRefGoogle Scholar
  78. 78.
    Rizwan SB, Assmus D, Boehnke A, Hanley T, Boyd BJ, Rades T, et al. Preparation of phytantriol cubic by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm. 2011;79:15–22.  https://doi.org/10.1016/j.ejpb.2010.12.034.CrossRefGoogle Scholar
  79. 79.
    Dong YD, Larson I, Hanley T, Boyd BJ. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir. 2006;22:9512–8.  https://doi.org/10.1021/la061706v.CrossRefGoogle Scholar
  80. 80.
    Vadim C, Jeffrey C, Miroslav ZP, et al. Room to move: crystallizing membrane proteins in swollen lipidic mesophases. J Mol Biol. 2006;357:1605–18.  https://doi.org/10.1016/j.jmb.2006.01.049.CrossRefGoogle Scholar
  81. 81.
    Leonie VH, Connie D, Le TC, et al. In meso crystallization: compatibility of different lipid bicontinuous cubic mesophases with the cubic crystallization screen in aqueous solution. Cryst Growth Des. 2014;14:1771–81.  https://doi.org/10.1021/cg4018954.CrossRefGoogle Scholar
  82. 82.
    Liron BC, Dima L, Dietmar A, et al. Reversed hexagonal lyotropic liquid crystal and open shell glycodendrimers as potential vehicles for sustained release of Na-DFC. J Phys Chem B. 2014;118:4016–24.  https://doi.org/10.1021/jp4125974.CrossRefGoogle Scholar
  83. 83.
    Marganit CA, Libster D, Aserin A, et al. Sodium diclofenac and cell-penetrating peptides embedded in HII mesophases: physical characterization and delivery. J Phys Chem B. 2011;115:10189–97.  https://doi.org/10.1021/jp112067v.CrossRefGoogle Scholar
  84. 84.
    Liron BC, Dima L, Maria FO, et al. Structural behavior and interactions of dendrimer within lyotropic liquid crystals, monitored by EPR spectroscopy and rheology. J Phys Chem B. 2012;116:2420–9.  https://doi.org/10.1021/jp212008a.CrossRefGoogle Scholar
  85. 85.
    Liron BC, Aserin A, Garti N. The effect of dendrimer generations on the structure of QG LLC mesophase and drug release. Colloids Surf B: Biointerfaces. 2014;122:30–7.  https://doi.org/10.1016/j.colsurfb.2014.05.013.CrossRefGoogle Scholar
  86. 86.
    Kwak SJ, Lafleur M. Effect of dimethyl sulfoxide on the phase behavior of model stratum corneum lipid mixtures. Chem Phys Lipids. 2009;161:11–21.  https://doi.org/10.1016/j.chemphyslip.2009.06.141.CrossRefGoogle Scholar
  87. 87.
    Hoffman RE, Darmon E, Aserin A, Garti N. High accuracy NMR chemical shift corrected for bulk magnetization as a tool for structural elucidation of dilutable microemulsions. Part 1—proof of concept. J Colloid Interface Sci. 2016;463:349–57.  https://doi.org/10.1016/j.jcis.2014.06.041.CrossRefGoogle Scholar
  88. 88.
    Takaaki M, Yasuo Y, Etsuo Y, et al. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. Int J Pharm. 2012;422:160–9.  https://doi.org/10.1016/j.ijpharm.2011.10.046.CrossRefGoogle Scholar
  89. 89.
    Groen D, Berthaud F, Bouwstra JA, Chapuis C, Gooris GS, Boncheva M. In vitro model systems for studying the impact of organic chemicals on the skin barrier lipids. Biochim Biophys Acta. 2014;1838:310–8.  https://doi.org/10.1016/j.bbamem.2013.10.006.CrossRefGoogle Scholar
  90. 90.
    Song ZH, Xin X, Shen JL, Jiao J, Xia C, Wang S, et al. Manipulation of lyotropic liquid crystal behavior of ionic liquid-type imidazolium surfactant by amino acids. Colloids Surf A Physicochem Eng Asp. 2017;518:7–14.  https://doi.org/10.1016/j.colsurfa.2017.01.004.CrossRefGoogle Scholar
  91. 91.
    Natali AZ, Aserin A, Garti N. Food volatile compounds facilitating HII mesophase formation: solubilization and stability. J Agric Food Chem. 2011;59:5554–64.  https://doi.org/10.1021/jf200466e.CrossRefGoogle Scholar
  92. 92.
    Paul BI, Dima L, Abraham A, et al. Influence of cyclosporine A on molecular interactions in lyotropic reverse hexagonal liquid crystals. J Phys Chem B. 2010;114:12785–91.  https://doi.org/10.1021/jp104028m.CrossRefGoogle Scholar
  93. 93.
    Tehila M, Maria FO, Alexander IS, et al. Structural effects of insulin-loading into HII mesophases monitored by electron paramagnetic resonance (EPR), small angle X-ray spectroscopy (SAXS), and attenuated total reflection Fourier transform spectroscopy (ATR-FTIR). J Phys Chem B. 2011;115:8054–62.  https://doi.org/10.1021/jp2034455.CrossRefGoogle Scholar
  94. 94.
    Lidich N, Ottaviani MF, Hoffman RE, et al. Docosahexaenoic acid triglyceride-based microemulsions with an added dendrimer—structural considerations. J Colloid Interface Sci. 2016;483:374–84.  https://doi.org/10.1016/j.jcis.2016.08.036.CrossRefGoogle Scholar
  95. 95.
    Patil SS, Venugopal E, Bhat S, Mahadik KR, Paradkar AR. Probing influence of mesophasic transformation on performance of self-emulsifying system: effect of ion. Mol Pharm. 2012;9:318–24.  https://doi.org/10.1021/mp200541r.CrossRefGoogle Scholar
  96. 96.
    Hamid RM, Adrian CW, Brian WB. A lamellar matrix model for stratum corneum intercellular lipids. V. Effects of terpene penetration enhancers on the structure and thermal behaviour of the matrix. Int J Pharm. 1997;146:41–54.CrossRefGoogle Scholar
  97. 97.
    Hamid RM, Adrian CW, Brian WB. A lamellar matrix model for stratum corneum intercellular lipids. I. Characterisation and comparison with stratum corneum inter-cellular structure. Int J Pharm. 1996;131:103–15.CrossRefGoogle Scholar
  98. 98.
    Rubio L, Alonso C, Rodríguez G, Cócera M, Barbosa-Barros L, Coderch L, et al. Bicellar systems as vehicle for the treatment of impaired skin. Eur J Pharm Biopharm. 2014;86:212–8.  https://doi.org/10.1016/j.ejpb.2013.05.012.CrossRefGoogle Scholar
  99. 99.
    Mohamed N, Mohamed KG, Ahmed A, et al. In vitro and in vivo evaluation of cubic containing 5-fluorouracil for liver targeting. Acta Pharm Sin B. 2015;5:79–88.  https://doi.org/10.1016/j.apsb.2014.12.001.CrossRefGoogle Scholar
  100. 100.
    Shifra R, Maria FO, Alexander IS, et al. Behavior of PPI-G2 dendrimer in a microemulsion. J Phys Chem B. 2017;121:2339–49.  https://doi.org/10.1021/acs.jpcb.6b10237.CrossRefGoogle Scholar
  101. 101.
    Nina L, Ellen JW, Abraham A, et al. Water-dilutable microemulsions for transepithelial ocular delivery of riboflavin phosphate. J Colloid Interface Sci. 2016;463:342–8.  https://doi.org/10.1016/j.jcis.2015.02.011.CrossRefGoogle Scholar
  102. 102.
    Chu JL, Cheng YL, Rao AV, Nouraei M, Zarate-Muñoz S, Acosta EJ. Lecithin-linker formulations for self-emulsifying delivery of nutraceuticals. Int J Pharm. 2014;471:92–102.  https://doi.org/10.1016/j.ijpharm.2014.05.001.CrossRefGoogle Scholar
  103. 103.
    Sarah F, Ellen JW, Abraham A, et al. Solubilization of simvastatin and phytosterols in a dilutable microemulsion system. Colloids Surf B: Biointerfaces. 2013;107:35–42.  https://doi.org/10.1016/j.colsurfb.2013.01.036.CrossRefGoogle Scholar
  104. 104.
    Libster D, Aserin A, Garti N. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications. J Colloid Interface Sci. 2011;356:375–86.  https://doi.org/10.1016/j.jcis.2011.01.047.CrossRefGoogle Scholar
  105. 105.
    Efrat R, Aserin A, Garti N. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac. J Colloid Interface Sci. 2008;321:166–76.  https://doi.org/10.1016/j.jcis.2008.01.013.CrossRefGoogle Scholar
  106. 106.
    Balázs B, Sipos P, Danciu C, Avram S, Soica C, Dehelean C, et al. ATR-FTIR and Raman spectroscopic investigation of the electroporation-mediated transdermal delivery of a nanocarrier system containing an antitumour drug. Biomed Opt Express. 2015;7:67–78.  https://doi.org/10.1364/BOE.7.000067.CrossRefPubMedPubMedCentralGoogle Scholar
  107. 107.
    Audrius M, Gediminas N, Zita T, et al. Infrared and Raman bands of phytantriol as markers of hydrogen bonding and interchain interaction. Spectrochim Acta A. 2005;62:945–57.  https://doi.org/10.1016/j.saa.2005.03.024.CrossRefGoogle Scholar
  108. 108.
    Zhao YR, Yue X, Wang XD, Chen X. Lyotropic liquid crystalline phases with a series of N-alkyl-N-methylpiperidinium bromides and water. J Colloid Interface Sci. 2013;389:199–205.  https://doi.org/10.1016/j.jcis.2012.09.032.CrossRefGoogle Scholar
  109. 109.
    Feast GC, Lepitre T, Tran N, Conn CE, Hutt OE, Mulet X, et al. Inverse hexagonal and cubic micellar lyotropic liquid crystalline phase behaviour of novel double chain sugar-based amphiphiles. Colloids Surf B: Biointerfaces. 2017;151:34–8.  https://doi.org/10.1016/j.colsurfb.2016.12.004.CrossRefGoogle Scholar
  110. 110.
    Calixto GM, Garcia MH, Cilli EM, Chiavacci L, Chorilli M. Design and characterization of a novel p1025 peptide-loaded liquid crystalline system for the treatment of dental caries. Molecules. 2016;21:158.  https://doi.org/10.3390/molecules21020158.CrossRefGoogle Scholar
  111. 111.
    Souza C, Watanabe E, Aires CP. Effect of liquid crystalline systems containing antimicrobial compounds on infectious skin bacteria. AAPS PharmSciTech. 2017;18:2110–9.  https://doi.org/10.1208/s12249-016-0690-0.CrossRefGoogle Scholar
  112. 112.
    Carvalho AL, Silva JA, Lira AA, et al. Evaluation of microemulsion and lamellar liquid crystalline systems for transdermal zidovudine delivery. J Pharm Sci. 105:2188–93.  https://doi.org/10.1016/j.xphs.2016.04.013.
  113. 113.
    Verma P. Cubic liquid crystalline nanoparticles: optimization and evaluation for ocular delivery of tropicamide. Drug Deliv. 2016;23:3043–54.  https://doi.org/10.3109/10717544.2016.1143057.CrossRefGoogle Scholar
  114. 114.
    Gabr MM, Mortada SM. Hexagonal liquid crystalline nanodispersions proven superiority for enhanced oral delivery of rosuvastatin: in vitro characterization and in vivo pharmacokinetic study. J Pharm Sci. 2017;106:3103–12.  https://doi.org/10.1016/j.xphs.2017.04.060.CrossRefGoogle Scholar
  115. 115.
    Liu R, Wang S, Fang S, Wang J, Chen J, Huang X, et al. Liquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: development, characterization, and in vitro and in vivo evaluation. Nanoscale Res Lett. 2016;11:254.  https://doi.org/10.1186/s11671-016-1471-0.CrossRefPubMedPubMedCentralGoogle Scholar
  116. 116.
    Dante MCL, Borgheti-Cardoso LN, Fantini MCA, et al. Liquid crystalline systems based on glyceryl monooleate and penetration enhancers for skin delivery of celecoxib: characterization, in vitro drug release, and in vivo studies. J Pharm Sci. 2018;107:870–8.  https://doi.org/10.1016/j.xphs.2017.10.039.CrossRefGoogle Scholar
  117. 117.
    Li Q, Cao JJ, Li ZG, Chu X. Cubic liquid crystalline gels based on glycerol monooleate for intra-articular injection. AAPS PharmSciTech. 2017;2017:858–65.  https://doi.org/10.1208/s12249-017-0894-y.CrossRefGoogle Scholar
  118. 118.
    Souza C, Watanabe E, Borgheti-Cardoso LN, de Abreu Fantini MC, Lara MG. Mucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochloride. J Pharm Sci. 2014;103:3914–23.  https://doi.org/10.1002/jps.24198.CrossRefGoogle Scholar
  119. 119.
    Liu Q, Hu J, Whittaker MR, Davis TP, Boyd BJ. Nitric oxide-sensing actuators for modulating structure in lipid-based liquid crystalline drug delivery systems. J Colloid Interface Sci. 2017;508:517–24.  https://doi.org/10.1016/j.jcis.2017.08.079.CrossRefGoogle Scholar
  120. 120.
    Angelova A, Angelov B, Mutafchieva R, Lesieur S, Couvreur P. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery. Acc Chem Res. 2011;44:147–56.  https://doi.org/10.1021/ar100120v.CrossRefGoogle Scholar
  121. 121.
    Otte A, Soh BK, Yoon G. Liquid crystalline drug delivery vehicles for oral and IV/subcutaneous administration of poorly soluble (and soluble) drugs. Int J Pharm. 2018;539:175–83.  https://doi.org/10.1016/j.ijpharm.2018.01.037.CrossRefGoogle Scholar
  122. 122.
    Huang JY, Peng TT, Li YR, Zhan Z, Zeng Y, Huang Y, et al. Ocular cubosome drug delivery system for timolol maleate: preparation, characterization, cytotoxicity, ex vivo, and in vivo evaluation. AAPS PharmSciTech. 2017;18:2919–26.  https://doi.org/10.1208/s12249-017-0763-8.CrossRefGoogle Scholar
  123. 123.
    Martiel IB, Baumann N, Vallooran JJ, Bergfreund J, Sagalowicz L, Mezzenga R. Oil and drug control the release rate from lyotropic liquid crystals. J Control Release. 2015;204:78–84.  https://doi.org/10.1016/j.jconrel.2015.02.034.CrossRefGoogle Scholar
  124. 124.
    Barauskas J, Cervin C, Jankunec M, Špandyreva M, Ribokaitė K, Tiberg F, et al. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Int J Pharm. 2010;391:284–91.  https://doi.org/10.1016/j.ijpharm.2010.03.016.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Xingqi Wang
    • 1
  • Yong Zhang
    • 1
  • Shuangying Gui
    • 1
    • 2
  • Jie Huang
    • 1
  • Jiaojiao Cao
    • 1
  • Zhengguang Li
    • 1
  • Qian Li
    • 1
  • Xiaoqin Chu
    • 1
    • 2
  1. 1.Department of Pharmaceutics, College of PharmacyAnhui University of Chinese MedicineHefeiChina
  2. 2.Institute of PharmaceuticsAnhui Academy of Chinese MedicineHefeiChina

Personalised recommendations